Table 1

Characteristics of the adrenocortical tumours submitted to LOH analyses

CaseSexAge (years)SideTumour functionSize (cm)LOH (D2S markers)MI (D2S markers)
Cu, Cushing syndrome; F, female; L, left; LOH, loss of heterozygosity; M, male; MI, microsatellite instability; R, right; Vi, virilisation.
1F0.5LVi4.5339; 408; 13631371; 126; 130
2F1.8LVi4.0×3.013631371; 163; 339; 130
3F2.0RVi+Cu4.2×3.51301371; 163; 126
4F0.8LVi6.013631371; 173; 163; 130; 408; 351
5M2.8LVi+Cu5.02061371; 173; 163
6M2.7RVi+Cu8.0×6.0339130; 1363; 206
7F2.1RVi6.3×5.13391371; 163; 130; 408
8F1.5RVi4.6×3.01371; 173
9F2.2LVi6.6×5.82061371; 173